AdvanSix Announces Second Quarter 2022 Financial Results
AdvanSix (ASIX) reported Q2 2022 sales of $584 million, a 33% increase year-over-year, driven by favorable market pricing and acquisitions. Net income rose to $65.2 million, with earnings per share at $2.23, and adjusted EPS at $2.30, up 40%. Cash flow from operations surged 85% to $96 million. The company announced a 16% increase in its quarterly dividend to $0.145 per share. Looking ahead, AdvanSix anticipates continued growth, backed by strong demand in North America and successful integration of U.S. Amines.
- Sales up 33% to $584 million due to market pricing and acquisitions.
- Net income increased by $21 million year-over-year to $65.2 million.
- Adjusted EPS rose by 40% to $2.30.
- Cash flow from operations increased by 85% to $96 million.
- Quarterly dividend increased by 16% to $0.145 per share.
- Sales volume decreased by 4% due to unfavorable weather impacting fertilizer demand.
Sales of
Earnings Per Share of
Cash Flow from Operations of
Announced
Second Quarter 2022 Summary
-
Sales up approximately
33% versus prior year driven by26% favorable impact of market-based pricing,6% higher raw material pass-through pricing, and5% contribution from acquisitions, partially offset by4% lower volume -
Net Income of
, an increase of$65.2 million versus the prior year$21.0 million -
Adjusted EBITDA of
, an increase of$105.4 million versus the prior year$25.7 million -
Cash Flow from Operations of
, an increase of$95.9 million versus the prior year$43.9 million -
Capital Expenditures of
, an increase of$17.8 million versus the prior year$7.5 million -
Free Cash Flow of
, an increase of$78.1 million versus the prior year$36.5 million -
Repurchased 87,251 shares for approximately
$3 million
“Our robust second quarter results, featuring top and bottom line growth sequentially and year-over-year, reflect the continued strength and advantage of our business model and diverse product portfolio," said
Summary second quarter 2022 financial results for the Company are included below:
($ in Thousands, Except Earnings Per Share) |
2Q 2022 |
|
2Q 2021 |
|
Sales |
|
|
|
|
Net Income |
65,157 |
|
44,131 |
|
Diluted Earnings Per Share |
|
|
|
|
Adjusted Diluted Earnings Per Share (1) |
|
|
|
|
Adjusted EBITDA (1) |
105,426 |
|
79,700 |
|
Adjusted EBITDA Margin % (1) |
|
|
|
|
Cash Flow from Operations |
95,891 |
|
51,945 |
|
Free Cash Flow (1)(2) |
78,131 |
|
41,644 |
|
(1) See “Non-GAAP Measures” included in this press release for non-GAAP reconciliations |
||||
(2) Net cash provided by operating activities less capital expenditures |
Sales of
Sales by product line and approximate percentage of total sales are included below:
($ in Thousands) |
2Q 2022 |
|
2Q 2021 |
|||||||
|
Sales |
|
% of Total |
|
Sales |
|
% of Total |
|||
Nylon |
$ |
132,105 |
|
|
|
$ |
111,710 |
|
|
|
Caprolactam |
|
87,169 |
|
|
|
|
81,792 |
|
|
|
Chemical Intermediates |
|
158,611 |
|
|
|
|
144,201 |
|
|
|
Ammonium Sulfate |
|
205,851 |
|
|
|
|
99,979 |
|
|
|
|
$ |
583,736 |
|
|
|
$ |
437,682 |
|
|
Adjusted EBITDA of
Adjusted earnings per share of
Cash flow from operations of
Dividend
The Company's Board of Directors declared a quarterly cash dividend of
Outlook
- Targeting significant earnings growth in 2022 supported by strength of our integrated business model and diverse end market exposure
-
Expect continued healthy
North America demand for nylon and chemical intermediates -
Expect favorable underlying agriculture industry fundamentals to continue;
North America ammonium sulfate seasonality expected to drive 3Q22 higher export mix sequentially -
Successful integration of
U.S. Amines expected to deliver year one earnings accretion -
Continue to expect Capital Expenditures to be
to$95 in 2022$105 million -
Continue to expect pre-tax income impact of planned plant turnarounds to be approximately
to$32 in 2022$37 million
"Looking forward, we expect continued healthy
Conference Call Information
About
Forward Looking Statements
This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements may be identified by words such as "expect," "anticipate," "estimate," “outlook,” "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should" and "believe" and other variations or similar terminology and expressions. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the
Non-GAAP Financial Measures
This press release includes certain non-GAAP financial measures intended to supplement, not to act as substitutes for, comparable GAAP measures. Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in this press release. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided. Non-GAAP measures in this press release may be calculated in a way that is not comparable to similarly-titled measures reported by other companies.
|
|||||||
Condensed Consolidated Balance Sheets |
|||||||
(Unaudited) |
|||||||
(Dollars in thousands, except share and per share amounts) |
|||||||
|
|
|
|
||||
ASSETS |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
17,297 |
|
|
$ |
15,100 |
|
Accounts and other receivables – net |
|
246,371 |
|
|
|
179,087 |
|
Inventories – net |
|
155,447 |
|
|
|
149,570 |
|
Other current assets |
|
16,798 |
|
|
|
6,097 |
|
Total current assets |
|
435,913 |
|
|
|
349,854 |
|
|
|
|
|
||||
Property, plant and equipment – net |
|
785,974 |
|
|
|
767,964 |
|
Operating lease right-of-use assets |
|
130,146 |
|
|
|
136,207 |
|
|
|
58,192 |
|
|
|
17,592 |
|
Intangible assets |
|
50,766 |
|
|
|
17,980 |
|
Other assets |
|
22,266 |
|
|
|
22,402 |
|
Total assets |
$ |
1,483,257 |
|
|
$ |
1,311,999 |
|
|
|
|
|
||||
LIABILITIES |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
272,261 |
|
|
$ |
211,511 |
|
Accrued liabilities |
|
43,449 |
|
|
|
49,712 |
|
Income taxes payable |
|
32 |
|
|
|
9,723 |
|
Operating lease liabilities – short-term |
|
38,995 |
|
|
|
36,127 |
|
Deferred income and customer advances |
|
1,607 |
|
|
|
2,749 |
|
Total current liabilities |
|
356,344 |
|
|
|
309,822 |
|
|
|
|
|
||||
Deferred income taxes |
|
148,263 |
|
|
|
133,330 |
|
Operating lease liabilities – long-term |
|
91,377 |
|
|
|
100,580 |
|
Line of credit – long-term |
|
146,500 |
|
|
|
135,000 |
|
Postretirement benefit obligations |
|
10,659 |
|
|
|
18,243 |
|
Other liabilities |
|
10,905 |
|
|
|
13,834 |
|
Total liabilities |
|
764,048 |
|
|
|
710,809 |
|
|
|
|
|
||||
STOCKHOLDERS' EQUITY |
|
|
|
||||
Common stock, par value |
|
320 |
|
|
|
318 |
|
Preferred stock, par value |
|
— |
|
|
|
— |
|
|
|
(39 |
) |
|
|
(36 |
) |
Additional paid-in capital |
|
192,392 |
|
|
|
195,931 |
|
Retained earnings |
|
532,246 |
|
|
|
411,516 |
|
Accumulated other comprehensive loss |
|
(5,710 |
) |
|
|
(6,539 |
) |
Total stockholders' equity |
|
719,209 |
|
|
|
601,190 |
|
Total liabilities and stockholders' equity |
$ |
1,483,257 |
|
|
$ |
1,311,999 |
|
|
|||||||||||||
Condensed Consolidated Statements of Operations |
|||||||||||||
(Unaudited) |
|||||||||||||
(Dollars in thousands, except share and per share amounts) |
|||||||||||||
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||
|
2022 |
|
2021 |
|
|
2022 |
|
2021 |
|||||
Sales |
$ |
583,736 |
|
$ |
437,682 |
|
|
$ |
1,062,809 |
|
|
$ |
814,065 |
|
|
|
|
|
|
|
|
||||||
Costs, expenses and other: |
|
|
|
|
|
|
|
||||||
Costs of goods sold |
|
476,835 |
|
|
356,884 |
|
|
|
852,482 |
|
|
|
674,783 |
Selling, general and administrative expenses |
|
20,841 |
|
|
21,682 |
|
|
|
42,051 |
|
|
|
40,990 |
Interest expense, net |
|
769 |
|
|
1,379 |
|
|
|
1,332 |
|
|
|
2,923 |
Other non-operating (income) expense, net |
|
172 |
|
|
(211 |
) |
|
|
(431 |
) |
|
|
19 |
Total costs, expenses and other |
|
498,617 |
|
|
379,734 |
|
|
|
895,434 |
|
|
|
718,715 |
|
|
|
|
|
|
|
|
||||||
Income before taxes |
|
85,119 |
|
|
57,948 |
|
|
|
167,375 |
|
|
|
95,350 |
Income tax expense |
|
19,962 |
|
|
13,817 |
|
|
|
39,145 |
|
|
|
23,088 |
Net income |
$ |
65,157 |
|
$ |
44,131 |
|
|
$ |
128,230 |
|
|
$ |
72,262 |
|
|
|
|
|
|
|
|
||||||
Earnings per common share |
|
|
|
|
|
|
|
||||||
Basic |
$ |
2.31 |
|
$ |
1.57 |
|
|
$ |
4.55 |
|
|
$ |
2.57 |
Diluted |
$ |
2.23 |
|
$ |
1.53 |
|
|
$ |
4.37 |
|
|
$ |
2.51 |
|
|
|
|
|
|
|
|
||||||
Weighted average common shares outstanding |
|
|
|
|
|
|
|
||||||
Basic |
|
28,168,207 |
|
|
28,131,981 |
|
|
|
28,183,951 |
|
|
|
28,112,978 |
Diluted |
|
29,262,709 |
|
|
28,920,177 |
|
|
|
29,316,792 |
|
|
|
28,830,727 |
|
|||||||||||||||
Condensed Consolidated Statements of Cash Flows |
|||||||||||||||
(Unaudited) |
|||||||||||||||
(Dollars in thousands) |
|||||||||||||||
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Cash flows from operating activities: |
|
|
|
|
|
|
|
||||||||
Net income |
$ |
65,157 |
|
|
$ |
44,131 |
|
|
$ |
128,230 |
|
|
$ |
72,262 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
||||||||
Depreciation and amortization |
|
17,534 |
|
|
|
16,629 |
|
|
|
34,226 |
|
|
|
32,733 |
|
Loss on disposal of assets |
|
441 |
|
|
|
349 |
|
|
|
800 |
|
|
|
433 |
|
Deferred income taxes |
|
3,077 |
|
|
|
5,575 |
|
|
|
2,558 |
|
|
|
7,812 |
|
Stock-based compensation |
|
2,005 |
|
|
|
3,744 |
|
|
|
5,379 |
|
|
|
6,107 |
|
Accretion of deferred financing fees |
|
154 |
|
|
|
141 |
|
|
|
309 |
|
|
|
282 |
|
Changes in assets and liabilities, net of business acquisitions: |
|
|
|
|
|
|
|
||||||||
Accounts and other receivables |
|
(23,743 |
) |
|
|
(15,878 |
) |
|
|
(52,145 |
) |
|
|
(29,048 |
) |
Inventories |
|
4,901 |
|
|
|
1,706 |
|
|
|
3,012 |
|
|
|
40,692 |
|
Accounts payable |
|
70,159 |
|
|
|
20,602 |
|
|
|
62,130 |
|
|
|
6,821 |
|
Income taxes payable |
|
(27,624 |
) |
|
|
— |
|
|
|
(9,691 |
) |
|
|
— |
|
Accrued liabilities |
|
2,897 |
|
|
|
3,663 |
|
|
|
(8,821 |
) |
|
|
4,575 |
|
Deferred income and customer advances |
|
(827 |
) |
|
|
(16,626 |
) |
|
|
(1,142 |
) |
|
|
(23,429 |
) |
Other assets and liabilities |
|
(18,240 |
) |
|
|
(12,091 |
) |
|
|
(19,792 |
) |
|
|
(10,205 |
) |
Net cash provided by operating activities |
|
95,891 |
|
|
|
51,945 |
|
|
|
145,053 |
|
|
|
109,035 |
|
|
|
|
|
|
|
|
|
||||||||
Cash flows from investing activities: |
|
|
|
|
|
|
|
||||||||
Expenditures for property, plant and equipment |
|
(17,760 |
) |
|
|
(10,301 |
) |
|
|
(38,779 |
) |
|
|
(24,478 |
) |
Acquisition of business |
|
1,133 |
|
|
|
— |
|
|
|
(97,456 |
) |
|
|
(9,523 |
) |
Other investing activities |
|
(925 |
) |
|
|
(251 |
) |
|
|
(1,221 |
) |
|
|
(482 |
) |
Net cash used for investing activities |
|
(17,552 |
) |
|
|
(10,552 |
) |
|
|
(137,456 |
) |
|
|
(34,483 |
) |
|
|
|
|
|
|
|
|
||||||||
Cash flows from financing activities: |
|
|
|
|
|
|
|
||||||||
Borrowings from line of credit |
|
82,000 |
|
|
|
50,500 |
|
|
|
230,500 |
|
|
|
104,500 |
|
Payments of line of credit |
|
(155,500 |
) |
|
|
(101,500 |
) |
|
|
(219,000 |
) |
|
|
(184,500 |
) |
Principal payments of finance leases |
|
(244 |
) |
|
|
(165 |
) |
|
|
(481 |
) |
|
|
(364 |
) |
Dividend payments |
|
(3,515 |
) |
|
|
— |
|
|
|
(7,032 |
) |
|
|
— |
|
Purchase of treasury stock |
|
(3,407 |
) |
|
|
(146 |
) |
|
|
(10,419 |
) |
|
|
(589 |
) |
Issuance of common stock |
|
318 |
|
|
|
45 |
|
|
|
1,032 |
|
|
|
46 |
|
Net cash used for financing activities |
|
(80,348 |
) |
|
|
(51,266 |
) |
|
|
(5,400 |
) |
|
|
(80,907 |
) |
|
|
|
|
|
|
|
|
||||||||
Net change in cash and cash equivalents |
|
(2,009 |
) |
|
|
(9,873 |
) |
|
|
2,197 |
|
|
|
(6,355 |
) |
Cash and cash equivalents at beginning of period |
|
19,306 |
|
|
|
14,124 |
|
|
|
15,100 |
|
|
|
10,606 |
|
Cash and cash equivalents at the end of period |
$ |
17,297 |
|
|
$ |
4,251 |
|
|
$ |
17,297 |
|
|
$ |
4,251 |
|
|
|
|
|
|
|
|
|
||||||||
Supplemental non-cash investing activities: |
|
|
|
|
|
|
|
||||||||
Capital expenditures included in accounts payable |
|
|
|
|
$ |
9,207 |
|
|
$ |
3,739 |
|
|
|||||||||||||||
Non-GAAP Measures |
|||||||||||||||
(Dollars in thousands, except share and per share amounts) |
|||||||||||||||
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow |
|||||||||||||||
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Net cash provided by operating activities |
$ |
95,891 |
|
|
$ |
51,945 |
|
|
$ |
145,053 |
|
|
$ |
109,035 |
|
Expenditures for property, plant and equipment |
|
(17,760 |
) |
|
|
(10,301 |
) |
|
|
(38,779 |
) |
|
|
(24,478 |
) |
Free cash flow (1) |
$ |
78,131 |
|
|
$ |
41,644 |
|
|
$ |
106,274 |
|
|
$ |
84,557 |
|
|
|
|
|
|
|
|
|
||||||||
(1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment |
The Company believes that this metric is useful to investors and management as a measure to evaluate our ability to generate cash flow from business operations and the impact that this cash flow has on our liquidity.
Reconciliation of Net Income to Adjusted EBITDA and Earnings Per Share to Adjusted Earnings Per Share |
|||||||||||||||
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Net income |
$ |
65,157 |
|
|
$ |
44,131 |
|
|
$ |
128,230 |
|
|
$ |
72,262 |
|
Non-cash stock-based compensation |
|
2,005 |
|
|
|
3,744 |
|
|
|
5,379 |
|
|
|
6,107 |
|
Non-recurring, unusual or extraordinary expenses |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Non-cash amortization from acquisitions |
|
551 |
|
|
|
65 |
|
|
|
752 |
|
|
|
109 |
|
One-time M&A costs |
|
— |
|
|
|
— |
|
|
|
277 |
|
|
|
172 |
|
Benefit from income taxes relating to reconciling items |
|
(439 |
) |
|
|
(578 |
) |
|
|
(995 |
) |
|
|
(986 |
) |
Adjusted Net Income |
|
67,274 |
|
|
|
47,362 |
|
|
|
133,643 |
|
|
|
77,664 |
|
Interest expense, net |
|
769 |
|
|
|
1,379 |
|
|
|
1,332 |
|
|
|
2,923 |
|
Income tax expense - adjusted |
|
20,401 |
|
|
|
14,395 |
|
|
|
40,141 |
|
|
|
24,074 |
|
Depreciation and amortization - adjusted |
|
16,982 |
|
|
|
16,564 |
|
|
|
33,474 |
|
|
|
32,624 |
|
Adjusted EBITDA |
$ |
105,426 |
|
|
$ |
79,700 |
|
|
$ |
208,590 |
|
|
$ |
137,285 |
|
|
|
|
|
|
|
|
|
||||||||
Sales |
$ |
583,736 |
|
|
$ |
437,682 |
|
|
$ |
1,062,809 |
|
|
$ |
814,065 |
|
|
|
|
|
|
|
|
|
||||||||
Adjusted EBITDA Margin (2) |
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
||||||||
(2) Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Sales |
|
Three Months Ended
|
|
Six Months Ended
|
||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Net Income |
$ |
65,157 |
|
$ |
44,131 |
|
$ |
128,230 |
|
$ |
72,262 |
Adjusted Net Income |
|
67,274 |
|
|
47,362 |
|
|
133,643 |
|
|
77,664 |
|
|
|
|
|
|
|
|
||||
Weighted-average number of common shares outstanding - basic |
|
28,168,207 |
|
|
28,131,981 |
|
|
28,183,951 |
|
|
28,112,978 |
Dilutive effect of equity awards and other stock-based holdings |
|
1,094,502 |
|
|
788,196 |
|
|
1,132,841 |
|
|
717,749 |
Weighted-average number of common shares outstanding - diluted |
|
29,262,709 |
|
|
28,920,177 |
|
|
29,316,792 |
|
|
28,830,727 |
|
|
|
|
|
|
|
|
||||
EPS - Basic |
$ |
2.31 |
|
$ |
1.57 |
|
$ |
4.55 |
|
$ |
2.57 |
EPS - Diluted |
$ |
2.23 |
|
$ |
1.53 |
|
$ |
4.37 |
|
$ |
2.51 |
Adjusted EPS - Basic |
$ |
2.39 |
|
$ |
1.68 |
|
$ |
4.74 |
|
$ |
2.76 |
Adjusted EPS - Diluted |
$ |
2.30 |
|
$ |
1.64 |
|
$ |
4.56 |
|
$ |
2.69 |
The Company believes the non-GAAP financial measures presented in this release provide meaningful supplemental information as they are used by the Company’s management to evaluate the Company’s operating performance, enhance a reader’s understanding of the financial performance of the Company, and facilitate a better comparison among fiscal periods and performance relative to its competitors, as these non-GAAP measures exclude items that are not considered core to the Company’s operations.
|
||||||||||
Appendix |
||||||||||
(Pre-tax income impact, Dollars in millions) |
||||||||||
Planned Plant Turnaround Schedule (3) |
||||||||||
|
1Q |
|
2Q |
|
3Q |
|
4Q |
|
FY |
|
2017 |
— |
|
|
|
|
|
|
|
|
|
2018 |
|
|
|
|
|
|
— |
|
|
|
2019 |
— |
|
|
|
|
|
|
|
|
|
2020 |
|
|
|
|
|
|
|
|
|
|
2021 |
|
|
|
|
— |
|
|
|
|
|
2022E |
|
|
|
|
|
|
— |
|
|
(3) Primarily reflects the impact of fixed cost absorption, maintenance expense, and the purchase of feedstocks which are normally manufactured by the Company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220804006037/en/
Media
(973) 526-1615
janeen.lawlor@advansix.com
Investors
(973) 526-1700
adam.kressel@advansix.com
Source:
FAQ
What were AdvanSix's Q2 2022 earnings results?
How did the quarterly dividend change for ASIX?
What factors contributed to AdvanSix's sales growth in Q2 2022?
What is the outlook for AdvanSix following Q2 2022 results?